A 59-year-old woman was referred to our laryngology clinic for a 2-month history of fluctuating vocal quality and poor projection after a prodromal upper respiratory infection. Her initial vocal quality was severely breathy. It had partially improved, but she still complained of vocal fatigue and lack of vocal volume. Physical exam demonstrated no significant abnormalities aside from severe breathy dysphonia with a maximum phonation time of just 3 seconds and abnormal vocal fold motion.
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A 59-year-old woman was referred to our laryngology clinic for a 2-month history of fluctuating vocal quality and poor projection after a prodromal upper respiratory infection. Her initial vocal quality was severely breathy. It had partially improved, but she still complained of vocal fatigue and lack of vocal volume. Physical exam demonstrated no significant abnormalities aside from severe breathy dysphonia with a maximum phonation time of just 3 seconds and abnormal vocal fold motion.
Videostroboscopy revealed sluggish adduction of the left vocal fold and arytenoid complex with a significant glottic gap throughout the phonatory cycle and decreased mucosal wave propagation. The patient was diagnosed with left true vocal fold paresis, and vocal fold augmentation was recommended to improve her glottic insufficiency.
For topical nasal anesthesia, 4% lidocaine mixed equally with oxymetazoline was sprayed into the nasal cavity, and a total of 5 ml of 4% lidocaine was delivered directly to the endolarynx using the operative port on a flexible laryngoscope. Injection laryngoplasty was performed using a 23-gauge flexible sclerotherapy needle directed through the laryngoscope ( figure, A) .
The paretic left vocal fold was augmented with 0.7 ml of hyaluronic acid delivered via a single posterior lateral injection (figure, B) . The patient had immediate improvement in glottic closure with increased vocal strength and projection.
Percutaneous or transoral vocal fold augmentation is a common in-office technique performed under local anesthesia, avoiding the high cost associated with direct laryngoscopy and general anesthesia in a hospital setting. Both approaches involve endoscopic imaging to visualize the injection site.
1,2 Transnasal injection using a flexible needle via the operative port of a flexible laryngoscope allows for intraoperative assessment of vocal quality during injection laryngoplasty, with decreased gag reflex compared to transoral techniques. 3 Transnasal vocal fold augmentation is tolerated well by patients, easy to perform, and can be done without an assistant. It allows for direct laryngeal delivery of numerous products including micronized Alloderm, hyaluronic acid, botulinum toxin, and steroid suspensions, among others. 4 Viscous injection materials such as fat or calcium hydroxyapatite may be challenging to deliver using the 23-gauge flexible needle. Flexible laryngoscopy is a standard skill of the trained otolaryngologist, and injection by this technique is learned easily compared to more challenging percutaneous approaches.
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Figure. A: A flexible sclerotherapy needle is advanced through the operative port on a distal chip high-definition flexible laryngoscope, and the needle is advanced directly into the vocal fold from above. B: The vocal fold is injected under direct vision to improve glottic closure, allowing for concurrent voicing to assess for vocal improvement.
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